Heart failure remains a significant cause of morbidity and mortality, affecting over five million patients in the United States. Continuous-flow left ventricular assist devices (LVAD) have become the standard of care for patients with end stage heart failure. This review highlights the current state of LVAD as a bridge to transplant (BTT) in patients requiring mechanical circulatory support (MCS).
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of Thoracic Disease|
|State||Published - Jan 1 2014|
- Bridge to transplant (BTT)
- Left ventricular assist devices (LVAD)
- Mechanical circulatory support (MCS)